Article: Scios Announces First Blood Test for Congestive Heart Failure Diagnosis; Shionogi Launches BNP Diagnostic Test in Japan

MOUNTAIN VIEW, Calif. and OSAKA, Japan, Aug. 27 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO) and Shionogi & Co., Ltd. today announced the introduction in Japan of the first blood test for the diagnosis and monitoring of congestive heart failure (CHF). Shionogi is marketing the test, which is based on the detection of BNP (b-type natriuretic peptide) levels in the blood, for use in hospital patients with acute heart failure or acute exacerbation of chronic heart failure. Shionogi developed the test under a license from Scios for the use of BNP antigen in Japan. Scios is seeking additional licensees to develop BNP-based diagnostic tests for heart failure applications in the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!